Home » Topics » Regulatory

Regulatory
RSS

FDA approves Sarafem for treatment of premenstrual dysphoric disorder

July 7, 2000

Ibandronate reported useful for improving outcome following endoprosthetic implant

July 6, 2000

New combination HCV therapy launched in Germany

July 6, 2000

Sibutramine demonstrates efficacy in urinary incontinence

July 5, 2000

Alcon claims use of AIT-082 and other neurotrophic factor enhancers in ophthalmic disorders

July 5, 2000

TAP withdraws Uprima NDA until further data available

July 5, 2000

Biovail completes development of controlled-release formulation of Celexa

July 5, 2000

Topiramate now claimed effective in schizophrenia

July 4, 2000

PathoGenesis begins clinical trial of TOBI in patients with severe bronchiectasis

July 4, 2000

CPMP recommends approval of Caelyx for treatment of advanced ovarian cancer

July 3, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...